State-of-the-Art Review: Use of Antimicrobials at the End of Life.

antibiotic stewardship end-of-life care hospice palliative care

Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
20 Mar 2024
Historique:
received: 12 05 2023
pubmed: 1 2 2024
medline: 1 2 2024
entrez: 1 2 2024
Statut: ppublish

Résumé

Navigating antibiotics at the end of life is a challenge for infectious disease (ID) physicians who remain deeply committed to providing patient-centered care and engaging in shared decision making. ID physicians, who often see patients in both inpatient and outpatient settings and maintain continuity of care for patients with refractory or recurrent infections, are ideally situated to provide guidance that aligns with patients' goals and values. Complex communication skills, including navigating difficult emotions around end-of-life care, can be used to better direct shared decision making and assist with antibiotic stewardship.

Identifiants

pubmed: 38301076
pii: 7596076
doi: 10.1093/cid/ciad735
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e27-e36

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Déclaration de conflit d'intérêts

Potential conflicts of interest. D. F. reports a National Institutes of Health grant (R25 AI 147369), unrelated to this work. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Auteurs

Daniel Karlin (D)

Division of General Internal Medicine, Department of Medicine, University of California, Los Angeles, California, USA.

Christine Pham (C)

Division of Infectious Diseases, Department of Medicine, University of California, Los Angeles, California, USA.
Department of Pharmaceutical Services, University of California, Los Angeles, California, USA.

Daisuke Furukawa (D)

Division of Infectious Diseases, Department of Medicine, Stanford University, Palo Alto, California, USA.

Ishminder Kaur (I)

Division of Infectious Diseases, Department of Pediatrics, University of California, Los Angeles, California, USA.

Emily Martin (E)

Division of General Internal Medicine, Department of Medicine, University of California, Los Angeles, California, USA.

Olivia Kates (O)

Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Tara Vijayan (T)

Division of Infectious Diseases, Department of Medicine, University of California, Los Angeles, California, USA.

Classifications MeSH